Evidence map›Paper›PMID 26066392›Full record

ArticleJournal of visualized experiments : JoVE2015

Encapsulation Thermogenic Preadipocytes for Transplantation into Adipose Tissue Depots.

Lu Xu, Qiwen Shen, Zhongqi Mao, L James Lee, Ouliana Ziouzenkova

Abstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Repurposing Disulfiram as an Anti-Obesity Drug: Treating and Preventing Obesity in High-Fat-Fed Rats.Diabetes, metabolic syndrome and obesity : targets and therapy · 2020
    Article
  2. Article
  3. Induction of innervation by encapsulated adipocytes with engineered vitamin A metabolism.Translational research : the journal of laboratory and clinical medicine · 2018
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Lu XuDepartment of Human Sciences, The Ohio State University.
Qiwen ShenDepartment of Human Sciences, The Ohio State University.
Zhongqi MaoDepartment of Minimally Invasive Surgery, The First Affiliated Hospital of Soochow University.
L James LeeNSF Nanoscale Science and Engineering Center for Affordable Nanoengineering of Polymeric Biomedical Devices, The Ohio State University.
Ouliana ZiouzenkovaDepartment of Human Sciences, The Ohio State University; ziouzenkova.1@osu.edu.
The Ohio State University · USFirst Affiliated Hospital of Soochow University · CN

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Jennifer A. Woyach · 1985 to 2026
$132.3M
University of Iowa Clinical and Translational Science Program (TL1)UL1RR025755 · NCRR · OHIO STATE UNIVERSITY · PI JACKSON, REBECCA D · 2008 to 2011
$26.3M
The Ohio State University Center for clinical and Translational ScienceUL1TR001070 · NCATS · OHIO STATE UNIVERSITY · PI JACKSON, REBECCA D · 2013 to 2017
$22.6M
Developing models for identification of therapeutic cell populationsR21OD017244 · OD · OHIO STATE UNIVERSITY · PI ZIOUZENKOVA, OULIANA ZIOUZENKOVA · 2014 to 2015
$419k
NCATS NIH HHS UL1 TR001070NCI NIH HHS P30 CA016058NCI NIH HHS P30CA16058NCRR NIH HHS UL1 RR025755NCRR NIH HHS UL1RR025755NIH HHS R21 OD017244NIH HHS R21OD017244
6 · The paper itself

Abstract

Cell encapsulation was developed to entrap viable cells within semi-permeable membranes. The engrafted encapsulated cells can exchange low molecular weight metabolites in tissues of the treated host to achieve long-term survival. The semipermeable membrane allows engrafted encapsulated cells to avoid rejection by the immune system. The encapsulation procedure was designed to enable a controlled release of bioactive compounds, such as insulin, other hormones, and cytokines. Here we describe a method for encapsulation of catabolic cells, which consume lipids for heat production and energy dissipation (thermogenesis) in the intra-abdominal adipose tissue of obese mice. Encapsulation of thermogenic catabolic cells may be potentially applicable to the prevention and treatment of obesity and type 2 diabetes. Another potential application of catabolic cells may include detoxification from alcohols or other toxic metabolites and environmental pollutants.

Indexed as

3T3-L1 CellsAdipocytesAdipose TissueAlginatesAnimalsCoculture TechniquesCytological TechniquesDrug CompoundingEnergy MetabolismGlucuronic AcidHexuronic AcidsLipid MetabolismMiceObesityPolylysineAlginatesGlucuronic AcidHexuronic AcidsPolylysine

Identifiers

PMID26066392
PMCPMC4467455
OpenAlexW1913640073

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.